The prevalence of rheumatic heart disease in Ethiopia: a systematic review and meta-analysis

Globally, more than 33 million people are living with rheumatic heart disease (RHD). A high prevalence of the disease is observed in people with poor socio-economic status, overcrowding, and low access to medical facilities. Even though different studies have been conducted in different settings, there is no reliable data regarding RHD prevalence. Therefore, the aim of this systematic review and meta-analysis was to estimate the pooled prevalence of RHD in Ethiopia. PubMed/Medline, SCOPUS, HINARI, and Google Scholar databases were used to search for peer-reviewed articles. Articles published in English between the years 1992 and 2022 September were considered. The pooled prevalence of RHD was calculated using a random-effect model at a 95% confidence interval, including the weight of each study. Finally, statistical meta-analysis STATA version 16.0 software was used to calculate the pooled prevalence of RHD.A total of twelve cross-sectional studies were included in the meta-analysis. Individual study prevalence ranges from 0.32 to 32.78%. The pooled prevalence of RHD was 3.19% (95% CI: 1.46–5.56%). The prevalence was higher among the population who visited hospitals at 5.42% (95% CI: 1.09–12.7%) compared to schoolchildren at 0.73% (95% CI: 0.30–1.34%) and community-based studies at 3.83% (95% CI: 3.16–4.55%). Addis Ababa had the lowest prevalence of RHD (0.75% (95% CI: 0.38–1.25%), whereas the highest prevalence was observed in the Amhara region (8.95% (95% CI: 7.21–11.06%). A significant variation in the overall estimated prevalence of RHD was not observed between males and females. Trial registration Protocol registration (PROSPERO): CRD42021251553, Date of registration May 28 2021 SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s40794-023-00192-y.